Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Roche Holdings Ltd ADR (RHHBY)

Roche Holdings Ltd ADR (RHHBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 220,745,600
  • Shares Outstanding, K 6,830,000
  • Annual Sales, $ 67,325 M
  • Annual Income, $ 12,808 M
  • 60-Month Beta 0.41
  • Price/Sales N/A
  • Price/Cash Flow 10.56
  • Price/Book 6.64
Trade RHHBY with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/01/24
  • Annual Dividend & Yield 0.85 (2.62%)
  • Most Recent Dividend 0.847 on 03/14/24
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.2000 +8.75%
on 05/02/24
33.0300 -3.86%
on 05/20/24
+0.8450 (+2.73%)
since 04/22/24
3-Month
29.2000 +8.75%
on 05/02/24
35.2100 -9.81%
on 03/12/24
-0.7350 (-2.26%)
since 02/22/24
52-Week
29.2000 +8.75%
on 05/02/24
40.4800 -21.55%
on 06/05/23
-8.0050 (-20.13%)
since 05/22/23

Most Recent Stories

More News
Pancreatic Cancer Battle Intensifies with Biotech Sector's Advanced Treatments

USA News Group – A new study is bringing hope in the fight against one of the deadliest cancers, revealing a blood test that can detect early-stage pancreatic cancer with 97% accuracy. This breakthrough...

ONCY : 1.0900 (-1.80%)
ONC.TO : 1.51 (unch)
RHHBY : 31.7550 (-1.75%)
MRUS : 44.27 (+1.26%)
MGNX : 4.66 (+9.39%)
IMRX : 1.5100 (-1.95%)
Forget Weight-Loss Drugs, Here's the Next Breakthrough Pharma Stock

There is another segment of the pharma industry that is as hot as weight-loss drugs: antibody-drug conjugates, or ADCs. These treatments will, in the near future, replace conventional chemotherapy, thanks...

PFE : 29.25 (+2.42%)
ABBV : 160.65 (-1.40%)
JNJ : 153.90 (+1.76%)
RHHBY : 31.7550 (-1.75%)
GMAB : 29.88 (+2.50%)
AZN : 78.81 (-0.47%)
DSNKY : 34.6525 (-1.30%)
MRK : 131.19 (+0.33%)
LLY : 800.29 (-0.36%)
NVO : 134.04 (-0.83%)
Can Ocugen Stock Keep Churning Higher?

This tiny biotech caught fire in 2024. Can it sustain the momentum?

RHHBY : 31.7550 (-1.75%)
VHT : 267.93 (+0.38%)
OCGN : 1.7600 (-4.86%)
2 Small-Cap Growth Stocks With Room To Run

These two small-cap growth stocks could be ready to run.

REGN : 992.17 (-0.18%)
RHHBY : 31.7550 (-1.75%)
ACHR : 3.47 (-0.29%)
OCUL : 6.20 (+1.64%)
Looking for an Easy Way to Earn Passive Income? This Vanguard ETF Pays a Dividend Yield of Nearly 4.9%.

Think globally with this high-yielding ETF.

TM : 217.46 (-0.87%)
NVS : 101.78 (-1.03%)
HSBC : 44.28 (-0.67%)
SHEL : 70.81 (-0.83%)
RHHBY : 31.7550 (-1.75%)
VYMI : 71.11 (-0.56%)
Why Roche Holdings Stock Popped Today

Roche's new Alzheimer's test has a long road ahead of it, but it may help boost the pharmaceutical company's slow growth rate.

RHHBY : 31.7550 (-1.75%)
LLY : 800.29 (-0.36%)
Can Recursion Pharmaceuticals Stock Double in 5 Years? Here's What It Would Take.

Recursion is playing the long game with its AI-focused approach to drug discovery and development.

RHHBY : 31.7550 (-1.75%)
RXRX : 9.46 (-0.53%)
Roche showcases new navify® digital solutions that generate operational insights for faster decision-making in diagnostics at HIMSS¹ 2024

Roche introduces its suite of navify operational excellence solutions, including navify Analytics and navify Monitoring, for use in laboratories and point of...

RHHBY : 31.7550 (-1.75%)
Beyond the GRANOLAS: JPMorgan Picks 3 Top Stocks to Bet on Europe

The renowned brokerage firm weighed in on its top stock picks from the European market, which could offer investors better value than the outsized GRANOLAS group of equities at current levels.

NVDA : 949.31 (-0.48%)
MSFT : 429.95 (+0.21%)
AMZN : 183.11 (-0.02%)
AAPL : 191.24 (-0.58%)
META : 470.20 (+1.20%)
GOOGL : 175.39 (-1.38%)
TSLA : 179.92 (-3.58%)
GS : 464.52 (-1.25%)
GSK : 45.69 (+2.77%)
RHHBY : 31.7550 (-1.75%)
NSRGY : 103.9599 (-0.68%)
NVS : 101.78 (-1.03%)
GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons

NetworkNewsWire Editorial Coverage : On Sept. 20, 2019, history was made when the U.S. Food and Drug Administration approved Rybelsus as the first oral glucagon-like peptide-1 (GLP-1) agonist for type...

LEXX : 2.70 (-9.70%)
AMGN : 313.17 (-0.53%)
LLY : 800.29 (-0.36%)
RHHBY : 31.7550 (-1.75%)
WW : 1.6800 (-1.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Basel, Switzerland-based Roche Holding Ltd. is a leading health care company focused on developing and commercializing innovative diagnostic and therapeutic products and services, which enable early detection and prevention of diseases as well as their treatment and monitoring. The company conducts its...

See More

Key Turning Points

3rd Resistance Point 32.7067
2nd Resistance Point 32.5733
1st Resistance Point 32.4467
Last Price 31.7550
1st Support Level 32.1867
2nd Support Level 32.0533
3rd Support Level 31.9267

See More

52-Week High 40.4800
Fibonacci 61.8% 36.1710
Fibonacci 50% 34.8400
Fibonacci 38.2% 33.5090
Last Price 31.7550
52-Week Low 29.2000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar